% alzhub.org library filter % Source: https://alzhub.org/research?author=Teunissen+CE % 41 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{pereira2021-34259835, author = {Pereira, J. B. and Janelidze, S. and Smith, R. and Mattsson-Carlgren, N. and Palmqvist, S. and Teunissen, C. E. and Zetterberg, H. and Stomrud, E. and others}, title = {{Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease}}, journal = {Brain : a journal of neurology}, year = {2021}, doi = {10.1093/brain/awab223}, pmid = {34259835}, url = {https://doi.org/10.1093/brain/awab223} } @article{palmqvist2025-40729527, author = {Palmqvist, S. and Whitson, H. E. and Allen, L. A. and Suarez-Calvet, M. and Galasko, D. and Karikari, T. K. and Okrahvi, H. R. and Paczynski, M. and Schindler, S. E. and Teunissen, C. E. and others}, title = {{Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings}}, journal = {Alzheimer's \& Dementia}, year = {2025}, doi = {10.1002/alz.70535}, pmid = {40729527}, url = {https://doi.org/10.1002/alz.70535} } @article{salvado2025-40952756, author = {Salvadó, G. and Janelidze, S. and Bali, D. and Dolado, A. O. and Therriault, J. and Brum, W. S. and Pichet Binette, A. and Stomrud, E. and Mattsson-Carlgren, N. and Palmqvist, S. and Coomans, E. M. and Teunissen, C. E. and others}, title = {{Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease}}, journal = {JAMA Neurology}, year = {2025}, doi = {10.1001/jamaneurol.2025.3217}, pmid = {40952756}, url = {https://doi.org/10.1001/jamaneurol.2025.3217} } @article{janelidze2021-34542571, author = {Janelidze, S. and Teunissen, C. E. and Zetterberg, H. and Allué, J. A. and Sarasa, L. and Eichenlaub, U. and Bittner, T. and Ovod, V. and others}, title = {{Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2021.3180}, pmid = {34542571}, url = {https://doi.org/10.1001/jamaneurol.2021.3180} } @article{bridel2019-31206160, author = {Bridel, C. and van Wieringen, W. N. and Zetterberg, H. and Tijms, B. M. and Teunissen, C. E. and {the NFL Group} and Alvarez-Cermeño, J. C. and Andreasson, U. and others}, title = {{Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis}}, journal = {JAMA neurology}, year = {2019}, doi = {10.1001/jamaneurol.2019.1534}, pmid = {31206160}, url = {https://doi.org/10.1001/jamaneurol.2019.1534} } @article{eikelboom2021-34413181, author = {Eikelboom, W. S. and van den Berg, E. and Singleton, E. H. and Baart, S. J. and Coesmans, M. and Leeuwis, A. E. and Teunissen, C. E. and van Berckel, B. N. M. and others}, title = {{Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations}}, journal = {Neurology}, year = {2021}, doi = {10.1212/wnl.0000000000012598}, pmid = {34413181}, url = {https://doi.org/10.1212/wnl.0000000000012598} } @article{khalil2024-38609644, author = {Khalil, M. and Teunissen, C. E. and Lehmann, S. and Otto, M. and Piehl, F. and Ziemssen, T. and Bittner, S. and Sormani, M. P. and others}, title = {{Neurofilaments as biomarkers in neurological disorders - towards clinical application}}, journal = {Nature reviews. Neurology}, year = {2024}, doi = {10.1038/s41582-024-00955-x}, pmid = {38609644}, url = {https://doi.org/10.1038/s41582-024-00955-x} } @article{verberk2021-36098162, author = {Verberk, I. M. W. and Laarhuis, M. B. and van den Bosch, K. A. and Ebenau, J. L. and van Leeuwenstijn, M. and Prins, N. D. and Scheltens, P. and Teunissen, C. E. and others}, title = {{Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study}}, journal = {The lancet. Healthy longevity}, year = {2021}, doi = {10.1016/s2666-7568(20)30061-1}, pmid = {36098162}, url = {https://doi.org/10.1016/s2666-7568(20)30061-1} } @article{slot2018-30081935, author = {Slot, R. E. R. and Verfaillie, S. C. J. and Overbeek, J. M. and Timmers, T. and Wesselman, L. M. P. and Teunissen, C. E. and Dols, A. and Bouwman, F. H. and others}, title = {{Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results}}, journal = {Alzheimer's research \& therapy}, year = {2018}, doi = {10.1186/s13195-018-0390-y}, pmid = {30081935}, url = {https://doi.org/10.1186/s13195-018-0390-y} } @article{scheltens2018-30309389, author = {Scheltens, P. and Hallikainen, M. and Grimmer, T. and Duning, T. and Gouw, A. A. and Teunissen, C. E. and Wink, A. M. and Maruff, P. and others}, title = {{Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study}}, journal = {Alzheimer's research \& therapy}, year = {2018}, doi = {10.1186/s13195-018-0431-6}, pmid = {30309389}, url = {https://doi.org/10.1186/s13195-018-0431-6} } @article{scheltens2021-33667416, author = {Scheltens, P. and De Strooper, B. and Kivipelto, M. and Holstege, H. and Chételat, G. and Teunissen, C. E. and Cummings, J. and van der Flier, W. M.}, title = {{Alzheimer's disease}}, journal = {Lancet (London, England)}, year = {2021}, doi = {10.1016/s0140-6736(20)32205-4}, pmid = {33667416}, url = {https://doi.org/10.1016/s0140-6736(20)32205-4} } @article{kester2015-26366630, author = {Kester, M. I. and Teunissen, C. E. and Crimmins, D. L. and Herries, E. M. and Ladenson, J. H. and Scheltens, P. and van der Flier, W. M. and Morris, J. C. and others}, title = {{Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease}}, journal = {JAMA neurology}, year = {2015}, doi = {10.1001/jamaneurol.2015.1867}, pmid = {26366630}, url = {https://doi.org/10.1001/jamaneurol.2015.1867} } @article{ebenau2020-32522798, author = {Ebenau, J. L. and Timmers, T. and Wesselman, L. M. P. and Verberk, I. M. W. and Verfaillie, S. C. J. and Slot, R. E. R. and van Harten, A. C. and Teunissen, C. E. and others}, title = {{ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000009724}, pmid = {32522798}, url = {https://doi.org/10.1212/wnl.0000000000009724} } @article{verberk2018-30196548, author = {Verberk, I. M. W. and Slot, R. E. and Verfaillie, S. C. J. and Heijst, H. and Prins, N. D. and van Berckel, B. N. M. and Scheltens, P. and Teunissen, C. E. and others}, title = {{Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes}}, journal = {Annals of neurology}, year = {2018}, doi = {10.1002/ana.25334}, pmid = {30196548}, url = {https://doi.org/10.1002/ana.25334} } @article{deleeuw2025-40638114, author = {de Leeuw, D. M. and Trieu, C. and Vromen, E. M. and Blujdea, E. R. and Verberk, I. M. W. and Duits, F. H. and Teunissen, C. E. and Pijnenburg, Y. A. L. and others}, title = {{Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum}}, journal = {JAMA network open}, year = {2025}, doi = {10.1001/jamanetworkopen.2025.19919}, pmid = {40638114}, url = {https://doi.org/10.1001/jamanetworkopen.2025.19919} } @article{vanmaurik2017-29049480, author = {van Maurik, I. S. and Zwan, M. D. and Tijms, B. M. and Bouwman, F. H. and Teunissen, C. E. and Scheltens, P. and Wattjes, M. P. and Barkhof, F. and others}, title = {{Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project}}, journal = {JAMA neurology}, year = {2017}, doi = {10.1001/jamaneurol.2017.2712}, pmid = {29049480}, url = {https://doi.org/10.1001/jamaneurol.2017.2712} } @article{duits2014-24721526, author = {Duits, F. H. and Teunissen, C. E. and Bouwman, F. H. and Visser, P. J. and Mattsson, N. and Zetterberg, H. and Blennow, K. and Hansson, O. and others}, title = {{The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2014}, doi = {10.1016/j.jalz.2013.12.023}, pmid = {24721526}, url = {https://doi.org/10.1016/j.jalz.2013.12.023} } @article{verhaar2021-35173707, author = {Verhaar, B. J. H. and Hendriksen, H. M. A. and de Leeuw, F. A. and Doorduijn, A. S. and van Leeuwenstijn, M. and Teunissen, C. E. and Barkhof, F. and Scheltens, P. and others}, title = {{Gut Microbiota Composition Is Related to AD Pathology}}, journal = {Frontiers in immunology}, year = {2021}, doi = {10.3389/fimmu.2021.794519}, pmid = {35173707}, url = {https://doi.org/10.3389/fimmu.2021.794519} } @article{vanderlee2018-29316447, author = {van der Lee, S. J. and Teunissen, C. E. and Pool, R. and Shipley, M. J. and Teumer, A. and Chouraki, V. and Melo van Lent, D. and Tynkkynen, J. and others}, title = {{Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2018}, doi = {10.1016/j.jalz.2017.11.012}, pmid = {29316447}, url = {https://doi.org/10.1016/j.jalz.2017.11.012} } @article{vanmaurik2019-31526625, author = {van Maurik, I. S. and Vos, S. J. and Bos, I. and Bouwman, F. H. and Teunissen, C. E. and Scheltens, P. and Barkhof, F. and Frolich, L. and others}, title = {{Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study}}, journal = {The Lancet. Neurology}, year = {2019}, doi = {10.1016/s1474-4422(19)30283-2}, pmid = {31526625}, url = {https://doi.org/10.1016/s1474-4422(19)30283-2} } @article{vanderflier2014-24614907, author = {van der Flier, W. M. and Pijnenburg, Y. A. and Prins, N. and Lemstra, A. W. and Bouwman, F. H. and Teunissen, C. E. and van Berckel, B. N. and Stam, C. J. and others}, title = {{Optimizing patient care and research: the Amsterdam Dementia Cohort}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2014}, doi = {10.3233/jad-132306}, pmid = {24614907}, url = {https://doi.org/10.3233/jad-132306} } @article{schoonenboom2012-22170879, author = {Schoonenboom, N. S. and Reesink, F. E. and Verwey, N. A. and Kester, M. I. and Teunissen, C. E. and van de Ven, P. M. and Pijnenburg, Y. A. and Blankenstein, M. A. and others}, title = {{Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort}}, journal = {Neurology}, year = {2012}, doi = {10.1212/wnl.0b013e31823ed0f0}, pmid = {22170879}, url = {https://doi.org/10.1212/wnl.0b013e31823ed0f0} } @article{dumurgier2022-35970577, author = {Dumurgier, J. and Sabia, S. and Zetterberg, H. and Teunissen, C. E. and Hanseeuw, B. and Orellana, A. and Schraen, S. and Gabelle, A. and others}, title = {{A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging}}, journal = {Neurology}, year = {2022}, doi = {10.1212/wnl.0000000000200735}, pmid = {35970577}, url = {https://doi.org/10.1212/wnl.0000000000200735} } @article{babapourmofrad2020-32788242, author = {Babapour Mofrad, R. and Tijms, B. M. and Scheltens, P. and Barkhof, F. and van der Flier, W. M. and Sikkes, S. A. M. and Teunissen, C. E.}, title = {{Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000010629}, pmid = {32788242}, url = {https://doi.org/10.1212/wnl.0000000000010629} } @article{kester2015-26383836, author = {Kester, M. I. and Teunissen, C. E. and Sutphen, C. and Herries, E. M. and Ladenson, J. H. and Xiong, C. and Scheltens, P. and van der Flier, W. M. and others}, title = {{Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort}}, journal = {Alzheimer's research \& therapy}, year = {2015}, doi = {10.1186/s13195-015-0142-1}, pmid = {26383836}, url = {https://doi.org/10.1186/s13195-015-0142-1} } @article{vanharten2013-24049134, author = {van Harten, A. C. and Smits, L. L. and Teunissen, C. E. and Visser, P. J. and Koene, T. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.}, title = {{Preclinical AD predicts decline in memory and executive functions in subjective complaints}}, journal = {Neurology}, year = {2013}, doi = {10.1212/wnl.0b013e3182a8418b}, pmid = {24049134}, url = {https://doi.org/10.1212/wnl.0b013e3182a8418b} } @article{meeter2018-29514947, author = {Meeter, L. H. H. and Vijverberg, E. G. and Del Campo, M. and Rozemuller, A. J. M. and Donker Kaat, L. and de Jong, F. J. and van der Flier, W. M. and Teunissen, C. E. and others}, title = {{Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum}}, journal = {Neurology}, year = {2018}, doi = {10.1212/wnl.0000000000005261}, pmid = {29514947}, url = {https://doi.org/10.1212/wnl.0000000000005261} } @article{kester2014-24818585, author = {Kester, M. I. and Goos, J. D. and Teunissen, C. E. and Benedictus, M. R. and Bouwman, F. H. and Wattjes, M. P. and Barkhof, F. and Scheltens, P. and others}, title = {{Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers}}, journal = {JAMA neurology}, year = {2014}, doi = {10.1001/jamaneurol.2014.754}, pmid = {24818585}, url = {https://doi.org/10.1001/jamaneurol.2014.754} } @article{prestia2013-23390179, author = {Prestia, A. and Caroli, A. and van der Flier, W. M. and Ossenkoppele, R. and Van Berckel, B. and Barkhof, F. and Teunissen, C. E. and Wall, A. E. and others}, title = {{Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease}}, journal = {Neurology}, year = {2013}, doi = {10.1212/wnl.0b013e3182872830}, pmid = {23390179}, url = {https://doi.org/10.1212/wnl.0b013e3182872830} } @article{yuan2023-37666862, author = {Yuan, J. and Pedrini, S. and Thota, R. and Doecke, J. and Chatterjee, P. and Sohrabi, H. R. and Teunissen, C. E. and Verberk, I. M. W. and others}, title = {{Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults}}, journal = {npj aging}, year = {2023}, doi = {10.1038/s41514-023-00114-4}, pmid = {37666862}, url = {https://doi.org/10.1038/s41514-023-00114-4} } @article{wojdala2025-39747866, author = {Wojdała, A. L. and Bellomo, G. and Gaetani, L. and Teunissen, C. E. and Parnetti, L. and Chiasserini, D.}, title = {{Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkers}}, journal = {Nature communications}, year = {2025}, doi = {10.1038/s41467-024-54878-8}, pmid = {39747866}, url = {https://doi.org/10.1038/s41467-024-54878-8} } @article{lemstra2017-27794030, author = {Lemstra, A. W. and de Beer, M. H. and Teunissen, C. E. and Schreuder, C. and Scheltens, P. and van der Flier, W. M. and Sikkes, S. A.}, title = {{Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies}}, journal = {Journal of neurology, neurosurgery, and psychiatry}, year = {2017}, doi = {10.1136/jnnp-2016-313775}, pmid = {27794030}, url = {https://doi.org/10.1136/jnnp-2016-313775} } @article{vanharten2013-23232269, author = {van Harten, A. C. and Visser, P. J. and Pijnenburg, Y. A. and Teunissen, C. E. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.}, title = {{Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2013}, doi = {10.1016/j.jalz.2012.08.004}, pmid = {23232269}, url = {https://doi.org/10.1016/j.jalz.2012.08.004} } @article{binnewijzend2016-26040647, author = {Binnewijzend, M. A. and Benedictus, M. R. and Kuijer, J. P. and van der Flier, W. M. and Teunissen, C. E. and Prins, N. D. and Wattjes, M. P. and van Berckel, B. N. and others}, title = {{Cerebral perfusion in the predementia stages of Alzheimer's disease}}, journal = {European radiology}, year = {2016}, doi = {10.1007/s00330-015-3834-9}, pmid = {26040647}, url = {https://doi.org/10.1007/s00330-015-3834-9} } @article{pijnenburg2015-27239528, author = {Pijnenburg, Y. A. and Verwey, N. A. and van der Flier, W. M. and Scheltens, P. and Teunissen, C. E.}, title = {{Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes}}, journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)}, year = {2015}, doi = {10.1016/j.dadm.2015.11.001}, pmid = {27239528}, url = {https://doi.org/10.1016/j.dadm.2015.11.001} } @article{smits2012-22366769, author = {Smits, L. L. and Pijnenburg, Y. A. and Koedam, E. L. and van der Vlies, A. E. and Reuling, I. E. and Koene, T. and Teunissen, C. E. and Scheltens, P. and others}, title = {{Early onset Alzheimer's disease is associated with a distinct neuropsychological profile}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2012}, doi = {10.3233/jad-2012-111934}, pmid = {22366769}, url = {https://doi.org/10.3233/jad-2012-111934} } @article{vermunt2019-31068481, author = {Vermunt, L. and van Paasen, A. J. L. and Teunissen, C. E. and Scheltens, P. and Visser, P. J. and Tijms, B. M. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal}}, journal = {Neurology}, year = {2019}, doi = {10.1212/wnl.0000000000007609}, pmid = {31068481}, url = {https://doi.org/10.1212/wnl.0000000000007609} } @article{teunissen2025-39625101, author = {Teunissen, C. E. and Kolster, R. and Triana-Baltzer, G. and Janelidze, S. and Zetterberg, H. and Kolb, H. C.}, title = {{Plasma p-tau immunoassays in clinical research for Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2025}, doi = {10.1002/alz.14397}, pmid = {39625101}, url = {https://doi.org/10.1002/alz.14397} } @article{willemse2021-34006321, author = {Willemse, E. A. J. and Scheltens, P. and Teunissen, C. E. and Vijverberg, E. G. B.}, title = {{A neurologist's perspective on serum neurofilament light in the memory clinic: a prospective implementation study}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00841-4}, pmid = {34006321}, url = {https://doi.org/10.1186/s13195-021-00841-4} } @article{teunissen2022-34838239, author = {Teunissen, C. E. and Verberk, I. M. W. and Thijssen, E. H. and Vermunt, L. and Hansson, O. and Zetterberg, H. and van der Flier, W. M. and Mielke, M. M. and others}, title = {{Blood-based biomarkers for Alzheimer's disease: towards clinical implementation}}, journal = {The Lancet. Neurology}, year = {2022}, doi = {10.1016/s1474-4422(21)00361-6}, pmid = {34838239}, url = {https://doi.org/10.1016/s1474-4422(21)00361-6} } @article{teunissen2002-12009495, author = {Teunissen, C. E. and de Vente, J. and Steinbusch, H. W. and De Bruijn, C.}, title = {{Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid}}, journal = {Neurobiology of aging}, year = {2002}, doi = {10.1016/s0197-4580(01)00328-1}, pmid = {12009495}, url = {https://doi.org/10.1016/s0197-4580(01)00328-1} }